BEAM

#1368
Beam Therapeutics Inc. - Common Stock
32.9 3 USD
-0.12%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
32.93
32.93
Faixa anual
15.35
36.44
Mudança diária
-0.12%
Mudança mensal
+11.59%
Mudança em 6 meses
+32.89%
Mudança anual
+103.90%
Fechamento anterior
32.9 7
Open
32.9 3
Mínimo
32.9 3
High
32.9 3
Volume
211
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26

Beam Therapeutics Inc. - Common Stock

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Notícias